Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 216

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 216
---
 | ​ | ​ | ​ | ​                          | ​ |    700,000 | ​ | ​ | ​ | ​                                | ​ |    700,000 | ​ | ​ | ​ | ​                          | ​ |    700,000 | ​ | ​ |
| Equity PIPE Investor                                                         | ​ | ​ | ​                                    | ​ |  1,500,000 | ​ | ​ | ​ | ​                          | ​ |  1,500,000 | ​ | ​ | ​ | ​                                | ​ |  1,500,000 | ​ | ​ | ​ | ​                          | ​ |  1,500,000 | ​ | ​ |
| Liminatus Members                                                            | ​ | ​ | ​                                    | ​ | 17,500,000 | ​ | ​ | ​ | ​                          | ​ | 17,500,000 | ​ | ​ | ​ | ​                                | ​ | 17,500,000 | ​ | ​ | ​ | ​                          | ​ | 17,500,000 | ​ | ​ |
| Pro forma weighted average Class A shares calculation, basic and diluted﻿(1) | ​ | ​ | ​                                    | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ | ​ | ​                                | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ |

(1) Number of shares determined based on a price of $10.00 per share. Such price is subject to adjustment based on the five day volume-weighted average price prior to the filing of a resale registration statement covering such shares.

97

TABLE OF CONTENTS

### SPECIAL MEETING OF IRIS STOCKHOLDERS

#### General
We are furnishing this proxy statement/prospectus to our stockholders as part of the solicitation of proxies by the Iris Board for use at the Special Meeting to be held on , 2025, and at any adjournment or postponement thereof. This proxy statement/prospectus is first being furnished to our stockholders on or about , 2025.

#### Date and Time of Special Meeting
The Special Meeting will be held at , Eastern Time, on , 2025, or such other date and time to which such meeting may be adjourned or postponed, for the purposes set forth in the accompanying notice.

The Special